NCT06173544

Brief Summary

This pilot study will individually randomize 105 adolescents living with HIV 1:1:1 to standard of care, adapted intervention, or enhanced intervention. The intervention is called the Friendship Bench Intervention is a counseling intervention for depression and engagement in HIV care.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
106

participants targeted

Target at P50-P75 for not_applicable depression

Timeline
Completed

Started Jul 2024

Geographic Reach
1 country

5 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 7, 2023

Completed
8 days until next milestone

First Posted

Study publicly available on registry

December 15, 2023

Completed
7 months until next milestone

Study Start

First participant enrolled

July 6, 2024

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 22, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 22, 2025

Completed
Last Updated

April 20, 2026

Status Verified

April 1, 2026

Enrollment Period

1.3 years

First QC Date

December 7, 2023

Last Update Submit

April 14, 2026

Conditions

Outcome Measures

Primary Outcomes (5)

  • Recruitment Rate (Intervention Feasibility)

    This measure is the ability to successfully enroll adolescents living with HIV (ALWH) in the pilot trial. Feasibility will be evaluated by measuring the recruitment rate (number of patients approached in order to accrue the final sample).

    Baseline

  • Number of participants retained in the study (Intervention Feasibility)

    This measure of feasibility will be measured as the ability to retain adolescents living with HIV (ALWH) in the pilot trial. Feasibility will be evaluated by measuring the number of participants retained in the study (number of patients enrolled at baseline who are still enrolled in the trial), through study completion.

    12 months

  • Proportion of sessions attended (Intervention Feasibility)

    The number of sessions attended by participants out of total number of sessions offered.

    12 Months

  • Number of sessions meeting Fidelity Threshold (Intervention Fidelity)

    Fidelity to content for sessions will be assessed by a member of the research team using a checklist of intervention characteristics. Intervention fidelity will be measured as the total number of sessions meeting or exceeding expectations for at least 80% of the total number of fidelity checklist items assessed per session.

    12 Months

  • Overall Satisfaction among Participants (Intervention Acceptability)

    Acceptability will be assessed through brief exit interviews with a sample of adolescents living with HIV (ALWH), all study staff, and supervisors. Exit interviews will assess how easy the intervention was to participate in or deliver, the perceived usefulness of the intervention, suggestions for improvement, and will explore contextual factors that impeded or facilitated implementation. Intervention acceptability will be measured as the number of participants who were either very satisfied or somewhat satisfied with the intervention. Satisfaction will be measured on a 4-point Likert scale-- 1 indicates high satisfaction and 4 indicates high dissatisfaction.

    12 Months

Secondary Outcomes (3)

  • Change in depression symptoms from baseline

    Baseline,12 months

  • Number of adolescents living with HIV who attended at least one appointment per quarter

    12 months

  • Number of Participants Achieving HIV Viral Suppression

    12 months

Study Arms (3)

Standard of Care (SOC)

ACTIVE COMPARATOR

35 adolescents living with HIV seeking HIV care at participating clinics in Lilongwe, Malawi will be enrolled in this study arm during study recruitment. Enhanced usual care will include general training of the HIV providers and clinics about common mental disorder (CMD) identification and management, and feedback to the HIV provider of the status of their enrolled patient to allow follow-up per the clinic's standard care. Enhanced usual care will included a mental health evaluation provided by a rained study nurse; brief supportive counseling; information, education, and support on depression; and (if indicated) facilitation of referral to the clinic's psychiatric nurse or mental health clinic or to the tertiary care hospital.

Behavioral: Standard of Care (SOC)

Adapted Friendship Bench (AFB)

EXPERIMENTAL

35 adolescents living with HIV seeking HIV care at participating clinics in Lilongwe, Malawi will be enrolled in this study arm during study recruitment. Individuals enrolled in this arm will receive 6 weekly counseling sessions per the AFB protocol.

Behavioral: Adapted Friendship Bench (AFB)

Enhanced Friendship Bench (EFB)

EXPERIMENTAL

35 adolescents living with HIV seeking HIV care at participating clinics in Lilongwe, Malawi will be enrolled in this study arm during study recruitment. Individuals enrolled in this arm will receive 6 weekly counseling sessions and peer support per the EFB protocol.

Behavioral: Enhanced Friendship Bench (EFB)

Interventions

Participants randomized to this arm will received enhanced standard of care.

Standard of Care (SOC)

Participants randomized to this arm will receive the Adapted Friendship Bench protocol delivered by a trained counselor.

Adapted Friendship Bench (AFB)

Participants randomized to this arm will receive the Enhanced Friendship Bench protocol delivered by a trained counselor and a peer supporter.

Enhanced Friendship Bench (EFB)

Eligibility Criteria

Age13 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • age 13-18
  • diagnosed with HIV (vertically or horizontally)
  • scored ≥ 13 on the self-reported and previously used BDI-II
  • living in the clinic's catchment area with intention to remain for \> 1 year
  • willing to provide consent (age 18 or 16-17 years old and married (emancipated minors per Malawi law) or assent with parental consent (age 13-17)

You may not qualify if:

  • Less than 13 or greater than 18 years of age

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (5)

Area 18 Health Centre

Lilongwe, Malawi

Location

Area 25 Health Centre

Lilongwe, Malawi

Location

Kawale Health Centre

Lilongwe, Malawi

Location

Lighthouse Health Centre

Lilongwe, Malawi

Location

UNC Project Malawi

Lilongwe, Malawi

Location

Related Publications (1)

  • Dao TTD, Gaynes BN, Pence BW, Mphonda SM, Kulisewa K, Udedi M, Stockton MA, Kramer J, Waddell KG, Faidas M, Mortensen H, Bhushan NL. Friendship Bench intervention to address depression and improve HIV care engagement among adolescents living with HIV in Malawi: Study protocol for a pilot randomized controlled trial. PLoS One. 2025 Mar 19;20(3):e0302666. doi: 10.1371/journal.pone.0302666. eCollection 2025.

MeSH Terms

Conditions

DepressionAnxiety DisordersAdolescent BehaviorHIV InfectionsImmune System Diseases

Interventions

Standard of Care

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehaviorMental DisordersBlood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency Syndromes

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Study Officials

  • Bradley N Gaynes, MD

    University of North Carolina, Chapel Hill

    PRINCIPAL INVESTIGATOR
  • Nivedita L Bhushan, PhD

    RTI International

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Three-Arm Individually Randomized Trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 7, 2023

First Posted

December 15, 2023

Study Start

July 6, 2024

Primary Completion

October 22, 2025

Study Completion

October 22, 2025

Last Updated

April 20, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will share

Deidentified individual data that supports the results will be shared beginning 9 to 36 months following publication provided the investigator who proposes to use the data has approval from an Institutional Review Board (IRB), Independent Ethics Committee (IEC), or Research Ethics Board (REB), as applicable, and executes a data use/sharing agreement with the University of North Carolina at Chapel Hill (UNC).

Time Frame
beginning 9 and continuing for 36 months after publication
Access Criteria
Investigator has approved IRB, IEC, or REB and an executed data use/sharing agreement with UNC.

Locations